CREST Choles: Chinese Registry Study on Treatment of Cholecysto-Choledocholithiasis

Sponsor
Beijing Friendship Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02554097
Collaborator
Peking University First Hospital (Other), Xuanwu Hospital, Beijing (Other), Luhe Hospital, Capital Medical University (Other), Peking University Third Hospital (Other), China-Japan Friendship Hospital (Other), Beijing Tongren Hospital (Other), LanZhou University (Other), The First Affiliated Hospital of Dalian Medical University (Other), Shanghai Zhongshan Hospital (Other), Peking University (Other), Peking Union Medical College Hospital (Other)
2,700
1
41
65.9

Study Details

Study Description

Brief Summary

Patients with gallstone and confirmed common bile duct stones are registered in this study. The three managements for common bile duct stones are endoscopic sphincterotomy (EST), laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative investigations, operative method, operative time, conversion to open procedure, intraoperative and postoperative complications, and the presence of retained and recurrent stones. All patients were followed up for 3 years by telephone interview ang outpatient visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom appeared during the follow-up period. If there were unusual findings, magnetic resonance cholangiopancreatography(MRCP) was carried out.

Condition or Disease Intervention/Treatment Phase
  • Procedure: endoscopic sphincterotomy
  • Procedure: laparoscopic common bile duct exploration
  • Procedure: laparoscopic transcystic common bile duct exploration
  • Procedure: laparoscopic cholecystectomy

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
2700 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System
Study Start Date :
Aug 1, 2015
Anticipated Primary Completion Date :
Dec 15, 2018
Anticipated Study Completion Date :
Dec 30, 2018

Arms and Interventions

Arm Intervention/Treatment
EST+LC group

Patients accept the management of endoscopic sphincterotomy and laparoscopic cholecystectomy.

Procedure: endoscopic sphincterotomy
Sphincterotomy (EST) is performed to remove the common bile duct stone.

Procedure: laparoscopic cholecystectomy
Laparoscopic cholecystectomy is performed to remove the gallbladder.

LCBDE+LC group

Patients accept the management of laparoscopic common bile duct exploration and laparoscopic cholecystectomy.

Procedure: laparoscopic common bile duct exploration
Transductal exploration was carried out to remove the common bile duct stone. Primary closure or a T tube drainage was performed according to the results of transductal surgery.

Procedure: laparoscopic cholecystectomy
Laparoscopic cholecystectomy is performed to remove the gallbladder.

LTCBDE+LC group

Patients accept the management of laparoscopic transcystic common bile duct exploration and laparoscopic cholecystectomy.

Procedure: laparoscopic transcystic common bile duct exploration
A wide local dissection of Calot's triangle is performed and a 2.8mm, 3-mm or 5-mm flexible choledochoscope according to the diameter of the cystic duct is inserted through the cystic duct into the common bile duct. After the common bile duct stone is removed, the cystic duct was ligated with Hem-o-lok.

Procedure: laparoscopic cholecystectomy
Laparoscopic cholecystectomy is performed to remove the gallbladder.

Outcome Measures

Primary Outcome Measures

  1. Rate of Adverse outcomes [3 years]

    The patients with complication / the total patients

Secondary Outcome Measures

  1. Incremental cost-effectiveness ratio [3 years]

    the average incremental cost associated with 1 additional unit of the measure of effect

  2. Hospital stay [3 years]

    The total days in hospital

  3. Acute cholangitis rate [30 days]

    The patients with acute cholangitis / the total patients

  4. Bile leakage rate [30 days]

    The patients with bile juice found in the abdominal cavity after procedures / the total patients

  5. Stricture of the bile duct rate rate [3 years]

    The patients with any stricture appeared after the procedures / the total patients

  6. Mortality [3 years]

    Number of death connected with the procedures and complications / total patients

  7. Perforation Rate [30 days]

    The patients with perforation after the procedures / the total patients

  8. Hemorrhage Rate [3 years]

    The patients with hemorrhage after the procedures / the total patients

  9. Operation time [3 years]

    The total time of all the procedures (min)

  10. Acute pancreatitis Rate [30 days]

    The patients with acute pancreatitis after the procedures / the total patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with age between 18 - 80 years.

  • Patients diagnosed with gallstones.

  • Patients diagnosed with common bile duct stone by one of the three exam (MRI、MRCP and CT).

  • Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration.

  • Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).

Exclusion Criteria:
  • Combined with Mirizzi syndrome and intrahepatic bile duct stones

  • Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD)

  • History of upper abdominal surgery.

  • Serious heart,brain,lung, metabolic diseases history.

  • Pregnant women

  • Unwillingness or inability to consent for the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Friendship Hospital Beijing Beijing China 100050

Sponsors and Collaborators

  • Beijing Friendship Hospital
  • Peking University First Hospital
  • Xuanwu Hospital, Beijing
  • Luhe Hospital, Capital Medical University
  • Peking University Third Hospital
  • China-Japan Friendship Hospital
  • Beijing Tongren Hospital
  • LanZhou University
  • The First Affiliated Hospital of Dalian Medical University
  • Shanghai Zhongshan Hospital
  • Peking University
  • Peking Union Medical College Hospital

Investigators

  • Study Chair: Zhongtao Zhang, Doctor, Beijing Friendship Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhongtao Zhang, Doctor, Beijing Friendship Hospital
ClinicalTrials.gov Identifier:
NCT02554097
Other Study ID Numbers:
  • CR-CREST Choles
First Posted:
Sep 18, 2015
Last Update Posted:
Nov 27, 2018
Last Verified:
Nov 1, 2018

Study Results

No Results Posted as of Nov 27, 2018